These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27439698)

  • 1. c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines.
    Pacheco-Pantoja EL; Dillon JP; Wilson PJ; Fraser WD; Gallagher JA
    Purinergic Signal; 2016 Dec; 12(4):647-651. PubMed ID: 27439698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors and effects of gut hormones in three osteoblastic cell lines.
    Pacheco-Pantoja EL; Ranganath LR; Gallagher JA; Wilson PJ; Fraser WD
    BMC Physiol; 2011 Jul; 11():12. PubMed ID: 21801348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
    Lund A; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1038-46. PubMed ID: 21386059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.
    Mieczkowska A; Bouvard B; Legrand E; Mabilleau G
    Front Endocrinol (Lausanne); 2021; 12():721506. PubMed ID: 34421828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-2 directly regulates hypothalamic neurons expressing neuropeptides linked to appetite control in vivo and in vitro.
    Dalvi PS; Belsham DD
    Endocrinology; 2012 May; 153(5):2385-97. PubMed ID: 22416082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala.
    Parker JA; McCullough KA; Field BC; Minnion JS; Martin NM; Ghatei MA; Bloom SR
    Int J Obes (Lond); 2013 Oct; 37(10):1391-8. PubMed ID: 23337772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor.
    Nuche-Berenguer B; Portal-Núñez S; Moreno P; González N; Acitores A; López-Herradón A; Esbrit P; Valverde I; Villanueva-Peñacarrillo ML
    J Cell Physiol; 2010 Nov; 225(2):585-92. PubMed ID: 20506394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gastrointestinal hormones in postprandial reduction of bone resorption.
    Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C
    J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat.
    Nelson DW; Sharp JW; Brownfield MS; Raybould HE; Ney DM
    Endocrinology; 2007 May; 148(5):1954-62. PubMed ID: 17234710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
    Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2.
    Sasaki-Hamada S; Ito K; Oka J
    Life Sci; 2013 Nov; 93(23):889-96. PubMed ID: 24383084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
    Züger D; Forster K; Lutz TA; Riediger T
    Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs.
    Zhan JK; Wang YJ; Wang Y; Tang ZY; Tan P; Huang W; Liu YS
    Int J Cardiol; 2015 Jun; 189():188-93. PubMed ID: 25897902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes.
    Christensen M; Knop FK; Vilsbøll T; Aaboe K; Holst JJ; Madsbad S; Krarup T
    Regul Pept; 2010 Aug; 163(1-3):96-101. PubMed ID: 20580750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
    Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.